COPENHAGEN, MAY 16, 2016 – AntibioTx and the Train2Target consortium, comprising leading academic groups and SME’s in the antimicrobial space, has been awarded a Horizon2020 grant to fund research and development. The grant will focus on antimicrobial resistance and in particular how to harness the challenges of the increasing problem with antibiotic resistance. Through the grant, AntibioTx will offer a PhD-position to a top-talented microbiologist who is passionate about the development of new antibacterial medicines.
This press release contains forward-looking statements. Forward-looking statements are statements that are not historical facts and can be identified by words such as committed, will, steps, may, can, portfolio, planned, advancing, look forward, expected, or similar words. These forward-looking statements are based upon current expectations, estimates, believed potentials and can, therefore, involve risks and uncertainties. Many of these risks and uncertainties can be difficult to predict and could be out of the control of AntibioTx A/S. We may not actually achieve our intended plans, and you should not place undue reliance on these forward-looking statements.
